Needham analyst Vikram Bagri initiates coverage on Lucid Gr (NASDAQ:LCID) with a Underperform rating.
Pfizer’s Q3 Earnings Surpasses Estimates, Lifts Forecasts For COVID-19 Vaccine Sales By $2B
Pfizer Inc (NYSE:PFE) has reported a Q3 adjusted EPS of $1.78, up 40% Y/Y, well ahead of the consensus of…